WebFeb 16, 2024 · Cisplatin is used together with other cancer drugs to treat bladder cancer, testicular cancer, or ovarian cancer. Cisplatin may also be used for purposes not listed in this medication guide. Warnings Cisplatin can affect your nervous system, increase your risk of bleeding or infection, or harm your kidneys. WebHuman colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins These results indicate that high-level resistance of human colon cancer cells to high doses of cisplatin and oxaliplatin does not seem to be related to acquired defects in the DNA MMR proteins.
Does adjuvant hepatic artery infusion chemotherapy improve …
WebWe investigated the activity and safety of first-line GEMOX compared with gemcitabine–carboplatin (GCb) in cisplatin-ineligible patients with advanced UCC. Methods: Treatment-naive, cisplatin-ineligible patients with advanced UCC were randomly assigned to GEMOX (gemcitabine 1000 mg/m 2 , oxaliplatin 100 mg/m 2 on day 1 [D1] … WebOct 5, 2014 · Cisplatin and oxaliplatin in combination with quercetin and thymoquinone in human ovarian tumour models is the best combination to treat ovarian cancer (Nessa, Beale et al., 2011). Olaparib in combination with Cisplatin has a synergistic effect on PTEN-Deficient lung cancer Cells (Minami, Takigawa et al., 2013). earth cam live feeds
Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin …
WebOxaliplatin, sold under the brand name Eloxatin among others, is a cancer medication (platinum-based antineoplastic class) used to treat colorectal cancer. It is given by … WebApr 11, 2024 · The effects of oxaliplatin on membrane CLDN1 expression were evaluated by flow cytometry, immunofluorescence and western blotting experiments in vitro and in vivo. Phosphoproteome analyses, proximity ligation and luciferase reporter assays were used to unravel the mechanism of CLDN1 induction. ... Moreover, it promotes cisplatin … WebResults: Cisplatin-induced neuropathy was more similar to neuropathy in patients receiving oxaliplatin than in those receiving paclitaxel. The cisplatin and oxaliplatin groups exhibited the coasting phenomenon and more prominent upper extremity symptoms than lower extremity symptoms during chemotherapy administration weeks. earth cam live airports